43
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Compliance with Antihypertensive Treatment

Pages 463-472 | Published online: 03 Jul 2009

References

  • Haynes R B. Introduction. Compliance in health care, R B Haynes, D W Taylor, D L Sackett. Johns Hopkins University Press, Baltimore 1979; 1–7
  • Saunders C E. patient compliance in filling prescriptions after discharge from the mergency department. Am J Emerg Med 1987; 5: 283–286
  • Brand F N, Smith R T, Brand P A. Effect of economic barriers to medical care on patient's noncompliance. Public Health Rep 1977; 92: 72–78
  • Nelson E C, Stason W B, Neutra R R, Solomon H S. Identification of the noncompliant hypertensive patient. Prev Med 1980; 9: 504–517
  • Haynes R B, Sackett D L, Taylor D W, Roberts R S, Johnson A L. Manipulation of the therapeutic regimen to imrove compliance: conceptions and misconceptions. Clin Pharmacol Ther 1977; 22: 125–130
  • Hilka B S. Patient-clinician interactions and compliance. Compliance in health care, R B Haines, D W Taylor, D L Sackett. Johns Hopkins University Press, Baltimore 1967; 63–77
  • Kubacka R T, Juhl R P. Attitudes of patients with hypertension or arthritis toward the frequency of medication administration. Am J Hosp Pharm 1985; 42: 2499–2501
  • Taggart A J, Johnston G D, McDevitt D G. Does the frequency of daily dosage influence compliance with digoxin therapy?. Br J Clin Pharmacol 1981; 1: 31–34
  • Ley P. Understanding, memory, satisfaction and compliance. Br J Clin Psychol 1982; 21: 241–254
  • Morisky D E, Green L W, Levine D M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74
  • Williams G H. Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents. Am J Kidney Dis 1987; 10(Suppl 1)61–65
  • Ley P. Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypoertens 1985; 3(Suppl 1)51–55
  • Mollica J A. Monitoring compliance through analysis of drug and metabolite levels. Contrib Clin Trials 1984; 5: 505–514
  • Fletcher S W, Pappius E M, Harper S J. Measurement of medication compliance in a clinical setting: comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979; 139: 635–638
  • Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987; 2: 23–35
  • Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: applications in ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990; 48: 676–685
  • Psaty B M, Koepsell T D, Wagner E H, LoGerfo J P, Inui T S. The relative risk of incident coronary heart disease associted with recently stopping the use of beta blockers. JAMA 1990; 263: 1653–1657
  • Glanz K, Kirscht J P, Rosenstock I M. Linking research and practice in patient education for hypertension, patient responses to four educational interventions. Med Care 1981; 19: 141–152
  • Mullen P D, Green L W, Persinger G S. Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Prev Med 1985; 14: 753–781
  • Edmonds D, Foerster E, Groth H, Greminger P, Siegenthaler W, Vetter W. Does self measurement of blood pressure improve patient compliance in hypertension?. J Hypertens 1985; 3(suppl 1)31–34

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.